NCT05526248
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05526248
Title A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide (ARAMON)
Acronym ARAMON
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Bayer
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Unio Specialty Care - Urology - Sherman Oaks Sherman Oaks California 91411 United States Details
Mass General Cancer Center Boston Massachusetts 02114-2696 United States Details
Beth Israel Deaconess Medical Center - Oncology Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Cancer Center New York - Main Campus New York New York 10065 United States Details
Central Ohio Urology Group - Gahanna Gahanna Ohio 43230 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field